Professor Adam Glaser
- Position: Professor of Paediatric Oncology and Late Effects
- Areas of expertise: Late effects of cancer in young people and adults; Patient reported outcomes research (PROMs); Fertility preservation and reproductive health in cancer patients; Child health.
- Email: A.Glaser@leeds.ac.uk
- Phone: +44(0)113 343 6265
- Location: 11.72 Worsley Building
I combine my clinical work with a research programme focusing on identification of the consequences of living with and beyond cancer. Whilst working at the Department of Health as Clinical Director of the National Cancer Survivor Initiative (2010-13), I identified a dearth of robust evidence to support the introduction of sustainable services for the increasingly prevalent section of society living with and beyond cancer. Consequently, I led the development of the National Cancer Patient Reported Outcome Measures (PROMs) Programme and successfully delivered the national colorectal cancer PROMs survey, the largest cancer PROMs exercise in the world to date.
My research group, the Cancer Survivor Intelligence Group, focuses on identifying the consequences of living with and beyond cancer. It includes the Prostate Cancer UK/Movember Foundation funded Life After Prostate Cancer Diagnosis programme and the Yorkshire Cancer Research Life and Bladder Cancer. We are exploring the personal and societal costs of cancer through the linkage of primary, secondary and tertiary health care records as part of a Macmillan Cancer Support funded programme CPR for Cancer Outcomes: The use of comprehensive patient records (CPR) to define the impact of cancer, co-morbidities and late-effects on individuals and the health service.
I am the clinical lead for the 6 bedded Children's Clincial Research Facility, part of the NIHR CRF@Leeds, and the Leeds Children's Hospital.
- Research Lead, Leeds Children's Hospital
- Clinical Lead, Children's Clinical Research Facility NIHR CRF@Leeds
Life after prostate cancer diagnosis, LAPCD programme. £2.1 miilion. Prostate Cancer UK/Movember Foundation. 2014-19
Life and bladder cancer, LABC programme. £ 377 K , Yorkshire Cancer Research. 20115-19.
CPR for cancer outcomes: The use of comprehensive patient records (CPR) to define the impact of cancer, co-morbidities and late-effects on individuals and the health service. £689 K, Macmillan Cancer Support. 2015-19.
Major grants over last 4 years
- Prostate Cancer UK. Life after prostate cancer diagnosis. Glaser A and Gavin A (PIs) £2,120,289. 2014-19. RGCACL102344
- Yorkshire Cancer Research. The Yorkshire Cancer Research Bladder Cancer Patient Reported Outcomes Survey. Catto J and Glaser A (PIs) £377,242. 2015-19. RGEPBI105338
- Macmillan Cancer Support. CPR for Cancer Outcomes: The use of comprehensive patient records (CPR) to define the impact of cancer, co-morbidities and late-effects on individuals and the health service. Glaser A & Hall G (PIs). £689,140.57. 2015-19. RGCAL106451
- Candlelighters Trust. Paediatric Oncology/haematology Research Fellowship Programme. 2015-21. Glaser A and Kinsey S (Joint Programme Leads) £2,1190,358.38. RGEPBI106374
- Macmillan Cancer Support. Evaluation of Patient-Reported Outcome (PRO) Protocol Content and Reporting in UK Cancer Clinical Trials – EPiC. Kyte D and Calvert M (PIs) Glaser A, Velikova G, Brown J co-investigators. 2016-18. £199,838.90.
- NIHR. PRESENT: Patient Reported Experience Survey Engineering of Natural Text: developing practical automated analysis and dashboard representations of cancer survey freetext answers. Rivas C et al. Glaser AW co-investigator. 11/15/- 5/17. £ 5,426 (Glaser) RGEPBI108558.
- BSc (Hons)
I lead an innovative research training programme for paediatric oncologists in training, enabling them to study for PhD and MD higher degrees. This £2 million programme is funded by Candlelilighters.
I have a successful track record of supervising post-graduate students and currently supervise both clincial and non-clinical students studying for PhDs.
In the last 5 years I have examined for PhDs nationally and internationally.
Research groups and institutes
- Leeds Institute of Medical Research at St James's
- Cancer Survivor Intelligence Group